Inhalation of vasoactive intestinal peptide in pulmonary hypertension Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis Source: Eur Respir J 2004; 24: 958-963 Year: 2004
Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006
Enhanced anti-inflammatory effects by combine inhaled nitric oxide and steroids in SARS patients and in a porcine sepsis model Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004
The vasoactive effects of helospectins I and II in vivo are not mediated by VIP and PACAP1-38 receptors or vasodilator prostaglandins Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002
Inhaled glucocorticoids and β-2 agonists regulate cytokine secretion from circulating blood cells Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma? Source: Eur Respir J 2001; 17: 1059-1061 Year: 2001
Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
A potentiating effect of endogenous nitric oxide in the physiologic secretion from airway submucosal glands Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Serum level of VIP (vasoactive intestinal polypeptide) in patients with COPD in stable state and during exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 483s Year: 2001
Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients Source: Eur Respir J 2003; 22: Suppl. 45, 5s Year: 2003
Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021
VIP (vasoactive intestinal polypeptide) and vitamin C in the serum of COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
The role of vasoactive intestinal peptide in regulation of bronchial tone in children with asthma during the period of exacerbation Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015
Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012
The effects of inhaled glucocorticoids on human neutrophil apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001